Walter Ian Lipkin

Title: Walter Ian Lipkin: Innovator in Viral Detection

Introduction

Walter Ian Lipkin is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of viral detection, holding a total of 16 patents. His work focuses on developing innovative methods and compositions for identifying viral infections, particularly those affecting public health.

Latest Patents

One of his latest patents is titled "Serological assay for the detection of zika virus-specific antibodies utilizing overlapping peptides comprising an NS2B epitope." This invention provides compositions, methods, and kits for detecting exposure to and infection by certain viruses. Specifically, it allows for the rapid differential serological detection of exposure to and infection by the Zika virus (ZIKV). Another notable patent is "Tilapia virus and uses thereof," which is directed to isolated Tilapia Lake Virus (TiLV) and isolated nucleic acid sequences and polypeptides thereof. This invention also relates to probes, primers, and antibodies against antigens from TiLV, as well as immunogenic compositions for inducing an immune response against TiLV in animals.

Career Highlights

Walter Ian Lipkin has had a distinguished career, working with esteemed institutions such as Columbia University and Ramot at Tel Aviv University Ltd. His research has significantly advanced the understanding of viral infections and their detection.

Collaborations

Throughout his career, Lipkin has collaborated with notable colleagues, including Thomas Briese and Nischay Mishra. These partnerships have contributed to the development of innovative solutions in the field of virology.

Conclusion

Walter Ian Lipkin's contributions to viral detection through his numerous patents highlight his role as a leading inventor in the field. His work continues to impact public health and the scientific community.